Tadalafil vs Insulin Glargine: side-by-side comparison
Tadalafil (PDE5 inhibitor) and Insulin Glargine (Long-acting insulin analogue) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Tadalafil | Insulin Glargine |
|---|---|---|
| Therapeutic class | PDE5 inhibitor | Long-acting insulin analogue |
| CAS | 171596-29-5 | 160337-95-1 |
| ATC | G04BE08 | A10AE04 |
| Molecular weight | 389.4 g/mol | 6063 Da |
| Brands with this active ingredient | 7 | 1 |
What they share
Tadalafil and Insulin Glargine share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Tadalafil acts by a different mechanism than Insulin Glargine, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Tadalafil: Tadalafil selectively inhibits PDE5, the enzyme responsible for breaking down cyclic guanosine monophosphate in the corpus cavernosum and other vascular smooth muscle. Insulin Glargine: Insulin glargine binds the insulin receptor with similar affinity to human insulin, activating intracellular signalling that increases glucose uptake in muscle and adipose tissue, suppresses hepatic glucose production an…
Indications compared
Tadalafil: Tadalafil is approved for three indications: erectile dysfunction in adult men, lower urinary tract symptoms associated with benign prostatic hyperplasia, and pulmonary arterial hypertension. Insulin Glargine: Insulin glargine is approved as basal insulin therapy in adults and paediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus when oral or non-insulin injectable therapy is insufficien…
Safety profile
Tadalafil: Common adverse effects in clinical trials include headache, dyspepsia, back pain, myalgia, nasal congestion and facial flushing. Insulin Glargine: Hypoglycaemia is the most important adverse effect of any insulin and can be severe in case of missed meals, prolonged exercise, alcohol intake or interaction with other glucose-lowering agents.
Frequently asked questions
Is Tadalafil better than Insulin Glargine? ▾
Tadalafil and Insulin Glargine are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Tadalafil and Insulin Glargine be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Tadalafil
Products with Insulin Glargine
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.